Key Things Labs Need to Know About the FDA’s Final LDTs Rule
This webinar will discuss steps lab leaders will need to take in the near future to ensure they are prepared for the final LDTs rule
OLP-Regular
Subscribe today for access to
Articles and Reports
A Debate—Resolved: Immunohistochemistry Should Be Regulated As An Assay
Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes
Don’t Sell Your Lab, Grow Your Lab
Join us and our experts to learn how labs can reimagine infrastructure utilization through collaboration to improve health system finances and enrich their value proposition
A Primer for New Lab Sales Managers
Join us and our expert to review important components a sales manager should consider in helping their staff be prepared, professional, and productive.
Uncovering the True Cost of Paper Forms: Why Forgoing Automation to Save Money May Cost You
This webinar will analyze the true cost of using manual paper requisition forms for laboratory testing, highlighting the financial and medical risks involved.
